Authors:
Bhol, KC
Desai, A
Kumari, S
Colon, JE
Ahmed, AR
Citation: Kc. Bhol et al., Pemphigus vulgaris: The role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production, CLIN IMMUNO, 100(2), 2001, pp. 172-180
Authors:
Sami, N
Bhol, KC
Beutner, EH
Plunkett, RW
Leiferman, KM
Foster, CS
Ahmed, AR
Citation: N. Sami et al., Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies, CLIN IMMUNO, 100(2), 2001, pp. 219-227
Authors:
Kumari, S
Bhol, KC
Rehman, F
Foster, CS
Ahmed, AR
Citation: S. Kumari et al., Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy, CYTOKINE, 14(4), 2001, pp. 218-224
Citation: L. Engineer et al., Bullous pemphigoid: Interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation, CYTOKINE, 13(1), 2001, pp. 32-38
Citation: Ms. Razzaque et al., Tissue and molecular events in human conjunctival scarring in ocular cicatricial pemphigoid, HIST HISTOP, 16(4), 2001, pp. 1203-1212
Citation: Ar. Ahmed, Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment, J AM ACAD D, 45(6), 2001, pp. 825-835
Citation: Ar. Ahmed, Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment, J AM ACAD D, 45(5), 2001, pp. 679-690
Citation: L. Engineer et Ar. Ahmed, Role of intravenous immunoglobulin in the treatment of bullous pemphigoid:Analysis of current data, J AM ACAD D, 44(1), 2001, pp. 83-88
Authors:
Kumari, S
Bhol, KC
Simmons, RK
Razzzaque, MS
Letko, E
Foster, CS
Ahmed, AR
Citation: S. Kumari et al., Identification of ocular cicatricial Pemphigoid antibody binding site(s) in human beta 4 integrin, INV OPHTH V, 42(2), 2001, pp. 379-385
Citation: N. Sami et al., Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses, CLIN EXP IM, 125(3), 2001, pp. 492-498
Citation: Ar. Ahmed et Je. Colon, Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid - Effects on disease progression in patients nonresponsive to dapsone therapy, ARCH DERMAT, 137(9), 2001, pp. 1181-1189
Citation: Kc. Bhol et al., Presence of interleukin 10 in the serum and blister fluid of patients withpemphigus vulgaris and pemphigoid, CYTOKINE, 12(7), 2000, pp. 1076-1083
Authors:
Engineer, L
Johnson, RE
Bhol, KC
Ahmed, AR
Citation: L. Engineer et al., Bovine gingival lysate: a novel substrate for rapid diagnosis of autoimmune vesiculobullous diseases - A preliminary observation, EXP DERMATO, 9(4), 2000, pp. 271-274